Elecsys (R) ProBNP Immunoassay for the diagnosis of congestive heart failure
Bywood, P, Merlin, T, Braunack-Mayer, A, Hiller, J
Record ID 32006000585
English
Authors' recommendations:
Currently Elecsys proBNP is used in hospital settings across Australia. Although the available evidence indicates its usefulness as a rule-out test for congestive heart failure (CHF), positive results should be interpreted with caution, requiring echocardiographic confirmation of CHF before providing treatment. Furthermore, the lack of good quality studies in a community setting limit speculation on the impact of primary care N-terminal brain natriuretic peptide (NT-proBNP) testing on patient outcomes.
Details
Project Status:
Completed
Year Published:
2004
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Heart Failure
- Immunoassay
- Natriuretic Peptide, Brain
- Peptide Fragments
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.